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ABSTRACT 
Objective: The present study aims to evaluate the anti-tumor potential of EEED (ethanolic extract of Ervatamia divaricata. L. Burkill) on EAC 
(Ehrlich ascites carcinoma). 
Methods: The ethanolic extract of Ervatamia divaricata. L. Burkill was subjected to preliminary phytochemical screening and the antitumor effect of 
EEED was assessed by employing in-vitro methods. Compounds present in the ethanol extract of the plant were identified using GC-MS (Gas 
chromatography-mass spectrometry) and attempts were made to understand the mechanism of action using insilico methods. 
Results: The results of the in vitro cytotoxicity assay and MTT assay revealed the anticancer potential of the ethanol extract of Ervatamia divaricata. 
When different concentrations of EEED were assayed, the dead cells were found to increase with increase in concentration of the extract. This 
proved that there was considerable damage of the cell membrane that leads to the blocking of the cell signaling in cancer cells. 
Conclusion: The present study revealed that EEED possessed significant antitumor activity against EAC. 
Keywords: Ervatamia divaricata, Ehrlich ascites carcinoma, In vitro, In silico. 
 
INTRODUCTION 
Malignant cancer disease is the second major killer disease in the world. 
As of 2013 GLOBACON statistical studies, the cancer burden rises to 4.2 
million new cancer cases and 8.2 million cancer-related deaths in 2012 
[1]. It is caused due to the disturbance in the homeostatic balance 
between normal cells and cancer cells. In practice, Synthetic drugs are 
widely used to kill cancer cells. Although synthetic drugs are effective in 
killing the cancer cells, the other side of it has serious life killing side 
effects also, because of the poor differentiating capability between the 
normal healthy cells and cancer cells [2]. This has ended-up in search of 
novel natural products in combating cancer cells. Ervatamia, a well 
known garden jasmine, is one of the genera of Apocynaceae family used 
since ancient times for its analgesic, anti infection, antioxidant, anti-
tumor, antibacterial and anti-inflammatory properties [3, 4]. This 
prompted us to evaluate the anti-tumor potential of the Ervatamia 
divaricata using in vitro and in silico studies. 
MATERIALS AND METHODS 
Plant material 
The leaves of Ervatamia divaricata. L. Burkill were obtained from the 
main campus of SASTRA University and the collected plant materials 
were identified and authenticated by Dr. P. Brindha, CARISM, 
SASTRA University. 
Preparation of leaf powder and extraction 
The leaves of Ervatamia divaricata were collected and shade dried. 
The dried leaves were mechanically powdered after keeping them at 
room temperature for 48 h. The powdered leaves were extracted 
with ethanol at room temperature. The ethanolic extract was filtered 
and evaporated to dryness using a distillation set-up. The 
concentrated extract was subjected to further analysis. 
Preliminary Phytochemical analysis 
The EEED was subjected to preliminary phytochemical analysis for the 
presence of tannins, terpenes, flavones, alkaloids, quinone, sterol, 
phenol, coumarin, proteins, reducing sugar, saponin, and gum [5]. 
Cells 
EAC cells were obtained from Jiva Janthu Pariksha Kendra, Central 
animal facility at SASTRA University. The EAC cell lines have 
resemblance with human tumors and hence it is highly sensitive to 
chemotherapy. EAC cell lines remain undifferentiated and 
hyperdiploid, have 100% malignancy, no regression, shorter life 
span, and high transplantable capability [6]. 
Maintenance of cells 
The carcinoma cells were maintained by intraperitoneal inoculation 
of 1 x 106
In vitro cytotoxicity assay 
cells/mouse weekly by the courtesy of Central animal 
facility, SASTRA University [7]. 
Short term in vitro cytotoxicity assay was done using EAC cell lines 
by incubating with four different concentrations of the EEED at 37 °C 
for 3 h. The carcinoma cells were aspirated from the peritoneal 
cavity of the mice using a 10 ml syringe and transferred to test tubes 
containing isotonic buffer solution. Then the cells were washed with 
normal saline and the cell number was determined using a 
hemocytometer and adjusted to 1 x 106
% dead cells (cytotoxicity) were calculated using the following formula, 
cells/ml. The different 
concentrations of the EEED were added to each test tube and the 
final volume was made up to 1 ml using the phosphate buffer 
solution. The tubes were kept in incubation at 37 °C for 3 h. After 
incubation, the cells were stained with 0.1 ml of 0.4% trypan blue to 
check for viability. The dead cells usually take up the blue stain 
because of the disrupted cell membrane. The dead cells (stained) 




EAC cell lines were cultured in 96 well plates with growth medium 
RPMI1640 and 10% FCS. Increasing concentrations of EEED were 
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added to the cells and incubated at 37 °C for 14 h in a CO2 incubator 
with 5 % CO2. The media were replaced with a fresh growth medium 
along with 20 μl of MTT [(3-(4,5-dimethylthiazol-2yl)-2,5-
diphennyltetrazoliumbromide]. Again, it was incubated for 4 h at 37 °C. 
After incubation, purple precipitate was clearly visible under the 
inverted microscope, then the growth medium was removed and 200 ml 
of 0.1% 0.1N acidic isopropyl alcohol was added to the cells to dissolve 
the MTT Formazan crystals. Then the covered plates were kept in the 
dark at 18-24 °C per overnight. The samples were drawn every 2 h and 
observed the reading at 570 nm. If the reading is low, the plate was 
returned for incubation. The plate cover was removed and the 
absorbance of the wells, including the blank at 570 nm. The absorbance 
was recorded at 570 nm immediately after the development of purple 
color. Each experiment was conducted in triplicate form. The average 
was calculated and compared with the control test samples [9]. 
The percentage growth inhibition was calculated using the following 
formula. 
% Growth Inhibition = (Control OD–Treated OD) × 100/Control OD 
Thin layer chromatography 
Thin layer chromatography was performed on glass plates, pre-
coated with Silica gel 60 F254 
GC-MS analysis 
as stationary phase. Toluene: Ethyl 
acetate: Diethylamine (70:20:10) were used as mobile phase. 80 ml 
of ether, 20 ml of alcohol and 5 ml of dilute ammonia was added to 5 
g of the extract and incubated for 1 h. The process was repeated 
until the colorless mixture was formed and filtered. 30 ml of 1N 
sulphuric acid was added to the filtrate and the bottom layer was 
collected in another separator. 25 ml of 3:1 alcohol and 0.5 N 
sulphuric acid was added and the acid layer was collected. 10 ml of 
chloroform was added to the acid layer and chloroform layer was 
collected and evaporated to dryness. The samples were loaded on 
the glass plates. The locations of the spots were determined under 
UV light at 254 nm and 366 nm.  
Perkin Elmer Clarus 500 GC-MS instrument was used to analyze the 
compounds present in the EEED. The capillary column was made of 
Elite 5ms (5% phenyl 95% dimethyl polysiloxane) of 30 m length 
was used. The oven program was fixed to 50ºC @ 8ºC/min to 220ºC 
(1 min) @ 7ºC/min to 280ºC (10 min). The split ratio was 1:10 and 
the carrier gas used was Helium at the flow rate of 1 ml/min. The 
samples were injected at 290 °C. The mass spectrometry was carried 
out with a mass range of 40-450 Daltons, the type of ionization was 
electron ionization (EI) and Gas-phase molecules enter the source 
through the heated probe or GC column. 1.12 x 10-
Insilico analysis 
[17] J electrons 
bombard molecules forming M+* ions that fragment in a unique, 
reproducible way to form a collection of fragment ions. The results 
were matched to the library NIST 2005 standards.  
To support the anticancer activity, the insilico approaches have been 
implemented in which the docking software Autodock 4.2 was used. 
The target molecule was chosen to be Vascular Endothelial Growth 
Factor Receptor-2 (VEGFR-2) as it is a tyrosine kinase receptor 
protein of VEGF; an angiogenic growth factor belongs to the family 
of angiogenic regulating proteins [10]. Compounds obtained from 
GC-MS were docked with VEGFR-2 and the results were found to be 
significant. 
RESULTS 
The Preliminary Phytochemical screening of the EEED indicated the 
presence of alkaloids, flavones, steroids and reducing sugars.  
In vitro cytotoxicity assay 
The percentage of dead cells increases as the concentration of the 
EEED increases against EAC cell lines as shown in table 1. Thus, the 
efficacy of the EEED in combating tumor cells has been proved.
 
Table 1: In vitro cytotoxicity assay of EEED on EAC cells 
Concentration of EEED (µg/ml) No. of viable cells Viable cells (%) No. of dead cells Dead cells (%) 
Control 91.67±0.58 96.84 3.67±1.53 4.21 
150 60.33±3.21 66.67 29.33±0.58 32.22 
300 40.67±0.58 45.56 49±3.61 54.44 
500 26.67±1.52 26.21 76.67±4.51 74.76 
1000 15.33±0.57 15.46 81.67±0.58 84.54 
No. of experimental runs = 3; Results are expressed as mean±SD. 
 
MTT assay 
MTT assay also revealed that % Cytotoxicity was found to be 
increasing with an increase in concentration of EEED that shows the 
anticancer property of Ervatamia divaricata that is indicated in table 2. 
 
Table 2: MTT assay of EEED on EAC cells 








Thin layer chromatography 
Thin layer chromatography was performed to spot out the alkaloids 
present in the ethanol extract of Ervatamia divaricata and the outcomes 
were shown in fig. 1(a) & 1(b) and Rf 
GC-MS Analysis 
values were given in table 3. 
The EEED was subjected to Gas chromatography-Mass spectrometry 
studies and the profile was shown in fig. 2. 
The major compounds obtained from GC-MS analysis were 3-amino-
2-oxazolidinone (Formula: C3H6N2O2 Molecular weight: 102.09 
g/gmol), 2-cyclopenten-1-one,2-hydroxy-(Formula: C5H6O2 
Molecular weight: 98.09 g/gmol), 2,5-Dimethyl-4-hydroxy-3(2H)-
furanone (Formula: C6H8O3 Molecular weight: 128.12 g/gmol), 
Benzoic acid,2-hydroxy-6-methyl ester (Formula: C8H8O3 Molecular 
weight: 152.14 g/gmol), Sucrose (Formula: C12H22O11 Molecular 
weight: 286), D-Allose (Formula: C6H12O6 Molecular weight: 120 
g/gmol), 4,6-Di-O-methyl-a-D-galactose (Formula: C8H12O6 
Molecular weight: 204.1 g/gmol) and, 2,4-Diaminophenol (Formula: 
C12H14N2O2 Molecular weight: 250.5 g/gmol), Quinoline,3-ethyl-
(Formula: C11H11N Molecular weight: 157.2 g/gmol), Benzene-
2(1,3-butadienyl)-1,3,5-trimethyl-(Formula: C13H16 Molecular 
weight: 172.26 g/gmol), Benzofuran,2,3-dihydro-(Formula: C8H8O 
Molecular weight: 120.1 g/gmol), 4H-pyran-4-one,2,3-dihydro-3,5-
hydroxy-6-methyl-(Formula: C6H8O4 Molecular weight: 144.1 
g/gmol), Benzyl Chloride (Formula: C7H7Cl Molecular weight: 
126.58 g/gmol), 5(2H)-Oxazolone,4-(phenylmethyl)-(Formula: 
C10H9NO2
In silico analysis 
 Molecular weight: 175.18 g/gmol). 
The major compounds obtained from GC-MS analysis was docked 
with VEGFR-2. As a result of docking, table 3 listed out the binding 
energies and number of hydrogen bonds interacted with the 
compounds. The best result was considered based on the Binding 
energy and Polar interactions. 
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Fig. 1: Thin layer chromatography plate viewed at 254 nm (fig. 
1a.) and 366 nm (fig. 1b.) 
    





















Fig. 2: GC-MS profile of Ethanolic extract of Ervatamia 
divaricata. L 
 
Table 3: Rf  
S. No. 
values of 9 spots viewed at 254 nm and 366 nm 
Rf R value at 254 nm f value at 366 nm 
1 0.09 0.09 
2 0.18 0.18 
3 0.27 0.27 
4 0.4 0.4 
5 0.52 0.52 
6 0.63 0.63 
7 0.67 0.67 
8 0.81 0.81 
9 0.98 0.98 
In fig. 3(a) and 3(b), the docking of sucrose and D-Allose with 
VEGFR-2 was shown respectively. The binding energies were found 
to be-25.32 kJ/mol and-22.64 kJ/mol and the no. of hydrogen atoms 




Fig. 3(a): Docking of Sucrose with VEGFR-2 
 
 
Fig. 3(b): Docking of D-Allose with VEGFR-2 
 
Table 3: Binding energy, no. of hydrogen bonds interacted with the compounds 
S. 
No. 
Ligand’s Name Structure Binding energy(G) 
(KJ/mol) 
No. of hydrogen bonds 
interacted with the compound 
1 3-amino-2-oxazolidinone 
 
-17.45  3 
2 2-cyclopenten-1-one,2-hydroxy- 
 
-73.04  4 
3 Benzyl Chloride 
 
-12.93  0 
4 2,5-Dimethyl-4-hydroxy-3(2H)-furanone 
 
-14.85  4 
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-15.73  1 
6 Benzoic acid,2-hydroxy-6-methyl ester  
 
-16.99  3 
7 Benzofuran,2,3-dihydro- 
 




-24.94  0 
9 Quinoline,3-ethyl- 
 
-23.48  0 
10 Sucrose 
 
-25.32  5 
11 D-Allose 
 
-22.64  6 
12 3’,5’-Dimethoxyacetophenone 
 
-21.84  1 
13 4,6-Di-O-methyl-a-D-galactose 
 
-16.03  4 
14 2,4-Diaminophenol 
 
-19.21  2 
15 5(2H)-Oxazolone,4-(phenylmethyl)- 
 
-17.91  1 
 
DISCUSSION 
Being the second major killer disease in the world, the plant kingdom 
is an excellent resource for the discovery of many anti-cancer drugs. 
Because of its “natural” origin, they are inherently safe and non-toxic 
to normal cells. They can act on multiple targets unlike synthetically 
produced drug molecules. The EEED has the ability to inhibit 
angiogenic pathways of tumor cells since angiogenesis is one of the 
most important criteria for tumor growth [11].  
Earlier reports [12] stated that Mallikarjuna G et al., 2013 evaluated 
the ethanolic extract of Sida cordifolia against AFB1 (Aflotoxin B1) 
induced HCC (hepatocellular carcinoma) in winstar rats 
(250μg/kg/dose). The results showed a significant restoration of 
abnormal serum and tissues indicating the protective effect [13]. 
The results of cytotoxic activity on hela cells treated with Sida 
cordifolia extracts showed cells with uncontrolled growth has been 
arrested and there is decline level of cancerous cells was studied by 
Joseph et al., 2011 [14]. The results of the present study with regard 
to in vitro cytotoxicity assay and MTT assay revealed the anticancer 
potential of the ethanol extract of Ervatamia divaricata. When 
different concentrations of EEED were assayed, the dead cells were 
found to increase with increase in concentration of the extract. The 
number of dead cells at 1000 μg/ml concentration of EEED was 
found to be 81.67 (table 1) which proves that the cancer cells were 
destroyed by the EEED. MTT assay also exhibited that the % 
cytotoxicity was found to be increasing with an increase in 
concentration of the plant extract. It was observed that 25 μg/ml of 
EEED showed 64.38% cytotoxicity (table 2). This proved that there 
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was considerable damage of the cell membrane that leads to the 
blocking of the cell signaling in cancer cells.  
The in silico analysis was done to study the anti-tumor activity of the 
active compounds present in this plant in detail. The structures 
obtained from GC-MS analysis were docked with the VEGFR-2 by 
which the molecular mechanism of action was studied. Among the 
major compounds, Sucrose and D-Allose were found to be the best to 
dock with the VEGFR-2 by means of polar interactions with binding 
energies of-25.32 kJ/mol and-22.64 kJ/mol respectively. 
CONCLUSION 
The present in vitro and in silico studies vividly show that the 
ethanol extract of Ervatamia divaricata possesses significant anti-
tumor activity. Hence the bioactive compounds in the plant can be 
developed as pharmacologically safe chemopreventive agents 
against cancer after carrying out thorough pre-clinical and clinical 
trials.  
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